Stockreport

Arbutus Provides Additional Data from the ARB-1467 Phase II Clinical Trial in HBV Patients [Canadian Business Journal (Canada)]

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF Arbutus Provides Additional Data from the ARB-1467 Phase II Clinical Trial in HBV Patients Complete Cohort 1 and 2 ARB-1467 Multi-Dose Data De [Read more]